Grand Laboratories, Inc. v. United States

882 F. Supp. 906, 1995 WL 244403
CourtDistrict Court, D. South Dakota
DecidedMarch 28, 1995
DocketNo. CIV 93-4051
StatusPublished
Cited by2 cases

This text of 882 F. Supp. 906 (Grand Laboratories, Inc. v. United States) is published on Counsel Stack Legal Research, covering District Court, D. South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grand Laboratories, Inc. v. United States, 882 F. Supp. 906, 1995 WL 244403 (D.S.D. 1995).

Opinion

MEMORANDUM OPINION AND ORDER

PIERSOL, District Judge.

Plaintiff sues defendant under the Federal Tort Claims Act (FTCA) for negligence, negligent supervision of agents, malicious prosecution, and abuse of process. Defendant moves to dismiss or, alternatively, for summary judgment, asserting that this suit is barred by the doctrine of res judicata, that this suit is barred by the discretionary function exception, 28 U.S.C. § 2680(a), and that Counts III and IV are barred by the law [908]*908enforcement exception, 28 U.S.C. § 2680(h). Plaintiff moves for summary judgment in its favor on the merits on Counts I and II. Because the Court concludes that the discretionary function exception bars this suit, the Court grants defendant’s motion to dismiss and denies plaintiffs motion for summary judgment.

I. FACTS AND PROCEDURAL HISTORY

The underlying facts of this case were the subject of a previous action brought by plaintiff against the United States Department of Agriculture (USDA). Grand Laboratories, Inc. v. United States Department of Agriculture, 10 F.3d 684 (8th Cir.1993). Plaintiff is a South Dakota corporation engaged in the manufacture of veterinary biological products. In 1986, Congress amended the Virus-Serum-Toxin Act, 21 U.S.C. §§ 151-158, to require that veterinary biological products sold intrastate must be manufactured under a license issued by the USDA. The amendments provided that the new licensing requirements would not take effect for four years and that the Secretary of Agriculture could grant an extension for a fifth year to a company showing “good cause and a good faith effort” to obtain the necessary license. In January 1987, plaintiff received the four year exemption for 154 products in various midwestern states. In December 1989, plaintiff received the additional fifth year exemption for 33 of its products.

In November 1990, when the fifth year extension was about to expire, the USDA published an interim rule providing that unlicensed products manufactured before January 1, 1991, could be shipped until June 30, 1991, provided the Secretary determined there was a reasonable expectation that li-censure would be completed by June 30, 1991. The interim rule was later adopted in a final regulation. 9 C.F.R. § 114.2(d)(6). Plaintiff received the additional six month shipment exemption for 16 of its products. “In adopting the final rule, the Secretary expressly rejected requests from Grand Labs and others ‘that products not authorized for shipment be allowed to be distributed through routine distribution channels for [an additional] six months or until such products had cleared distribution channels.’ 56 Fed. Reg. 7785, 7786 (1991).” Grand Laboratories, Inc., 10 F.3d at 586.

In June 1991, USDA agents told certain of plaintiffs distributors that the unlicensed products they received from plaintiff prior to June 30, 1991, could not be sold or shipped after June 30, 1991. The agents told the customers that veterinarians could continue to use the products in regular practice, but otherwise, the products had to be held without sale, destroyed, or shipped back to plaintiff. After some of the customers returned the products to plaintiff for refunds, plaintiff commenced an action in the District of Nebraska against the USDA challenging the agency’s interpretation of the applicable statutes and regulations. On September 30, 1992, the district court held that the agency’s ban on shipments of unlicensed products by the distributors after June 30, 1991, was a reasonable interpretation of the 1985 amendments, and granted defendant’s motion for summary judgment. (Doc. 1, Ex. C. at 9-10.) The Eighth Circuit affirmed the decision. Grand Laboratories, Inc., 10 F.3d at 587. On April 1, 1993, following the Nebraska district court’s decision, but while the appeal was pending, plaintiff filed this FTCA action in the District of South Dakota seeking $250,000 in damages from defendant for the June 1991 actions of the USDA agents.

II. DISCUSSION

Under the FTCA, the United States is liable for tort claims in the same manner and to the same extent as a private individual under like circumstances. 28 U.S.C. § 2674. Thus, a district court must look to state law for applicable standards. Livingston v. United States, 627 F.2d 165, 166 n. 1 (8th Cir.1980), cert. denied, 450 U.S. 914, 101 S.Ct. 1354, 67 L.Ed.2d 338 (1981).

Defendant first argues that this suit is barred by the doctrine of res judicata because the action arises out of the same subject matter litigated in Grand Laboratories, Inc., 10 F.3d at 587. Plaintiff argues that res judicata does not apply because the prior case was a “declaratory judgment action to construe the Virus Serum Toxin Act [909]*909and the regulations promulgated thereunder,” while this case is one for damages for “conduct involved in the implementation” of the statutory amendments and regulations. Plaintiff also argues that the claims asserted here could not have been raised in the previous suit because plaintiff had not administratively exhausted its claim with the USDA as required by 28 U.S.C. § 2675(a), and the Nebraska district court would have lacked subject matter jurisdiction. Plaintiff further argues that there are genuine issues of material fact as to what the USDA agents said to plaintiffs customers about use of plaintiffs products after June 30, 1991, and whether the agents’ actions constituted a detention, seizure, or destruction of the products that did not comport with the statutes and regulations. (Doc. 28, Plaintiffs Resistance at 3.)

The doctrine of res judicata serves to prevent the relitigation of an issue actually decided or which could have been properly raised and decided in a prior action. Matter of Guardianship of Janke, 500 N.W.2d 207, 209 (S.D.1993). The Court must apply four factors: (1) whether the issue decided in the prior case is identical to the present issue; (2) whether there was a final judgment on the merits; (3) whether the parties in the two actions are the same or in privity; and (4)whether there was a full and fair opportunity to litigate the issues in the prior ease. Id. The parties do not dispute that factors (2) and (3) are satisfied.

“Res judicata applies only if the second action is broúght on the same ‘cause of action’ as the first.” Hicks v. O’Meara, 31 F.3d 744, 746 (8th Cir.1994) (citation omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

SDDS, Inc. v. State
1997 SD 114 (South Dakota Supreme Court, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
882 F. Supp. 906, 1995 WL 244403, Counsel Stack Legal Research, https://law.counselstack.com/opinion/grand-laboratories-inc-v-united-states-sdd-1995.